Ironwood Pharmaceuticals, Inc. is a pharmaceutical company based in the United States specializing in both generic and specialty drugs. With a low risk rating score of 18.9, the company focuses on human therapeutics and innovative product opportunities in areas such as irritable bowel syndrome, gout, and gastroesophageal reflux disease. Ironwood Pharmaceuticals aims for growth through collaborative licenses, commercial agreements, and strategic acquisitions.